DSpace university logo mark
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > 120 熱帯医学研究所 > 120 紀要 > 熱帯医学 > 第35巻 第4号 >

A Rapporteur's Summary : Research on Dengue Vaccine

ファイル 記述 サイズフォーマット
tm35_04_28_t.pdf772.04 kBAdobe PDF本文ファイル

タイトル: A Rapporteur's Summary : Research on Dengue Vaccine
著者: Kitamura, Takashi
発行日: 1994年 3月31日
出版者: 長崎大学熱帯医学研究所 / Institute of Tropical Medicine, Nagasaki University
引用: 熱帯医学 Tropical medicine 35(4). p325-330, 1994
抄録: Dengue virus is a member of flavivirus group. Diseases caused by flaviviruses have been a scourge of mankind for long history of human kind; with yellow fever at the top, followed by dengue fever, Japanese encephalitis (JE) and Russian spring-summer encephalitis (RSSE). Due to the dvevelopment of a safe and efficacious live-attenuated vaccine against yellow fever as a first laboratory-designed virus vaccine, this disease is no longer a threat in countries where adequate vaccination is practiced. Similarly, safe and efficacious inactivated vaccines against JE and tick-borne encephalitis (TBE) have also been developed, resulting in dramatical reduction in the disease incidences. In spite of these successes, the development of vaccines against other pathogenic flaviviruses, such as dengue fever and RSSE have not been successful. Control of dengue virus became rather urgent because of the emergence of new syndrome, dengue hemorrhagic fever (DHF), which causes high mortality among infants. The present review attempts to summarize the characteristics of dengue fever and DHF, common features of flavivirus infections as the basis vaccine development and recent advances and problems encountered in dengue vaccine research.
URI: http://hdl.handle.net/10069/4660
ISSN: 03855643
資料タイプ: Departmental Bulletin Paper
出現コレクション:第35巻 第4号

引用URI : http://hdl.handle.net/10069/4660



Valid XHTML 1.0! Copyright © 2006-2015 長崎大学附属図書館 - お問い合わせ Powerd by DSpace